Parexel Launches Enhanced Integrated FSP Model
Parexel, a provider of solutions to accelerate the development and delivery of innovative new therapies to market to improve world health, from Clinical through to Commercialization, has launched an enhanced integrated outsourcing delivery model for Functional Service Provider (FSP.)
Parexel FSP consists of more than 5,000 specialized employees across the globe with a track record of achieving a 95 percent success rate in delivering repeat business.
Parexel’s customizable functional service solutions include Global Clinical Operations, Global Data Operations, Pharmacovigilance, Medical Affairs, Medical Writing, and Regulatory Support.
Learn more at www.parexel.com
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Related Articles
- Everything to Know About FDA’s Push Towards Radical Transparency in 2025
September 17th 2025
- IQVIA and Veeva Join Forces to Improve Efficiency and Patient Outcomes
September 17th 2025
- Managing Background Therapies in the NIMBLE Phase III Trial
September 17th 2025
- Generative AI Transforms Clinical Study Report Development
September 16th 2025